EOLS Evolus, Inc. Common Stock
$7.84▼ -0.89%
Healthcare
Other
After hours
$7.81▼ -0.38%
Sep 11, 7:32 PM ET
Volume 586.5K
Avg Volume (10D) 1.00M
Key Metrics & Fundamentals
Market Cap
$517.84M
P/E Ratio
–
Div Yield
–%
52W Range
3.86 - 9.31
% vs 50 MA
6.35%
% vs 200 MA
28.84%
RSI-14
43.5
MACD Histogram
-0.1900
Beta (1Y vs SPY)
1.12
Free Cash Flow
-$4.09M
Gross Rev
$84.08M
Gross Profit
$57.18M
EBITDA
-$1.34M
COGS
$26.90M
Operating Exp
$60.47M
Operating Income
-$3.29M
EBIT
-$3.29M
Pretax Income
-$8.21M
Net Income
-$8.05M
EPS (Diluted)
-0.12
Price & Volume History
Loading chart…
Recent News
Evolus (EOLS) Notches A Profit Milestone While Betting Big On The Future
Insider Monkey · Sep 9, 2026 6:10 AM
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture
CNW Group · Sep 1, 2026 3:37 PM
Telix Appoints David Gill as Chair
GlobeNewswire · Aug 31, 2026 10:21 PM
Wall Street Analysts Think Evolus (EOLS) Could Surge 77.68%: Read This Before Placing a Bet
Zacks · Aug 27, 2026 1:55 PM
Following Heightened Competition from Botox, Xeomin, and Long-Acting Daxxify, New Study Evaluates Dysport (abobotulinumtoxinA) Revenue Trajectory Through 2034
GlobeNewswire · Aug 17, 2026 2:56 PM
Wall Street Analysts Believe Evolus (EOLS) Could Rally 106.08%: Here's is How to Trade
Zacks · Aug 11, 2026 1:55 PM
Evolus Inc (EOLS) (Q2 2026) Earnings Call Highlights: Revenue Surges 21% and Adjusted EBITDA ...
GuruFocus.com · Aug 6, 2026 5:07 AM
Evolus Q2 Earnings Call Highlights
MarketBeat · Aug 6, 2026 1:03 AM
Evolus, Inc. (EOLS) Reports Break-Even Earnings for Q2
Zacks · Aug 6, 2026 12:35 AM
Evolus Reports Strong Second Quarter 2026 Financial Results; Delivers Third Consecutive Quarter of Positive Adjusted EBITDA and Raises Full-Year 2026 Financial Outlook
Business Wire · Aug 5, 2026 8:05 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See EOLS's money flow as a full page
Social Sentiment
Avg +0.50 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.